Pathway,Score
Signaling by VEGF,0.09880986124872015
Negative regulation of the PI3K/AKT network,0.003243703881959521
PI3K/AKT Signaling in Cancer,0.0007220628894617615
G beta:gamma signalling through PI3Kgamma,0.01826513425121776
G-protein beta:gamma signalling,-0.030095042821964294
VEGFA-VEGFR2 Pathway,0.007502668534189503
VEGFR2 mediated vascular permeability,0.006700260356690658
Constitutive Signaling by AKT1 E17K in Cancer,0.012547705603036781
Respiratory Syncytial Virus Infection Pathway,0.005786701167112242
RSV-host interactions,0.002955455889428868
RHO GTPases Activate WASPs and WAVEs,6.722099148288381e-05
RAC2 GTPase cycle,0.0024362195360401804
RAC3 GTPase cycle,-0.011848726105902003
Parasite infection,-0.0011196188668654429
Leishmania phagocytosis,0.0024178509129562814
FCGR3A-mediated phagocytosis,0.004301234864311607
Signaling by NOTCH1,0.020578373500765405
NOTCH1 Intracellular Domain Regulates Transcription,-0.044512906700443146
Signaling by NOTCH1 PEST Domain Mutants in Cancer,0.029671140781926744
Signaling by NOTCH1 in Cancer,-0.005705526490321362
Constitutive Signaling by NOTCH1 PEST Domain Mutants,-0.0736528993536243
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,-0.10485614712778395
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,-0.0027366901097369604
Regulation of PTEN gene transcription,0.006920319378148498
Budding and maturation of HIV virion,-0.0012052263453964933
Uptake and actions of bacterial toxins,0.008338978536173224
Bacterial Infection Pathways,0.007802682529576224
NRAGE signals death through JNK,0.002721443440853752
p75 NTR receptor-mediated signalling,-0.001470965450817797
"Cell death signalling via NRAGE, NRIF and NADE",0.009057109599848434
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,0.006472688401150875
Neurodegenerative Diseases,0.0605950154111397
Diseases of programmed cell death,0.026591349791046014
Defective Intrinsic Pathway for Apoptosis,-0.0001884267995204568
Signaling by SCF-KIT,-0.06656355318155038
Regulation of KIT signaling,0.01421419091281923
Degradation of beta-catenin by the destruction complex,0.008302923263748332
Beta-catenin phosphorylation cascade,0.00696228924562106
Disassembly of the destruction complex and recruitment of AXIN to the membrane,0.0006756110376461531
G alpha (12/13) signalling events,0.005207857167487596
Pre-NOTCH Transcription and Translation,-0.00935446156251626
Pre-NOTCH Expression and Processing,-0.021571618522540466
Signaling by NOTCH2,-0.19326007851320529
NOTCH2 intracellular domain regulates transcription,-0.12160756263515494
Signaling by NOTCH3,0.009773527803822239
NOTCH3 Intracellular Domain Regulates Transcription,0.0127186493365033
Signaling by NOTCH4,0.009446323128595226
NOTCH4 Intracellular Domain Regulates Transcription,0.0009922438687697504
Signaling by MET,0.0066410302102546965
RAS processing,0.002778671890516417
Potential therapeutics for SARS,-0.01252977437075945
Host Interactions of HIV factors,-0.036759596973951966
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,-0.0007301311687125542
The role of Nef in HIV-1 replication and disease pathogenesis,0.013372187893463035
NR1H2 and NR1H3-mediated signaling,-0.00030087738734325443
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,0.03016972098324973
Diseases of glycosylation,0.00666511499196065
Diseases associated with O-glycosylation of proteins,0.0019563039233931848
Defective GALNT3 causes HFTC,-0.0028460716964876062
Defective GALNT12 causes CRCS1,0.012083021059795172
Diseases of metabolism,-0.001333994574624827
Diseases of DNA repair,-0.0010056031624956236
Diseases of DNA Double-Strand Break Repair,-0.03961028977622529
Defective homologous recombination repair (HRR) due to BRCA2 loss of function,-0.08206885085036646
Defective homologous recombination repair (HRR) due to BRCA1 loss of function,0.0012948881410425842
Defective homologous recombination repair (HRR) due to PALB2 loss of function,-0.011130375994198064
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,-0.00015848834636008813
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,0.017005661446480056
Impaired BRCA2 binding to RAD51,0.00045703787328965737
Impaired BRCA2 binding to PALB2,-0.0005716906325274913
Effects of PIP2 hydrolysis,-0.03244560461068113
Integrin signaling,-0.002905315052617035
Retrograde neurotrophin signalling,0.00032840166331364005
Signaling by NTRK1 (TRKA),0.004614638112287027
TNFR1-induced proapoptotic signaling,0.00042978640521076407
Regulation of TNFR1 signaling,-0.0005807368715373513
TNFR1-induced NF-kappa-B signaling pathway,-0.0015579376626863163
TNF signaling,0.037440116463606565
RHOA GTPase cycle,0.06898154791283395
SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.002082006700403761
HCMV Infection,0.042009313398265816
HCMV Early Events,0.024325668122867853
Regulation of RAS by GAPs,0.000734107585419286
RHOF GTPase cycle,0.019198833092360965
P2Y receptors,-0.004233746014058384
Nucleotide-like (purinergic) receptors,0.010307141238504248
Signaling by PTK6,-0.00047723659238590034
Signaling by Non-Receptor Tyrosine Kinases,0.007241074968533668
Signaling by Retinoic Acid,-0.07550837108454247
RA biosynthesis pathway,-0.05604945198431028
Signaling by ERBB2,-0.009357443132336532
Downregulation of ERBB2 signaling,0.016418104650842043
Activated NOTCH1 Transmits Signal to the Nucleus,0.0006327936686636512
NOTCH2 Activation and Transmission of Signal to the Nucleus,-0.0024081613673613642
NOTCH3 Activation and Transmission of Signal to the Nucleus,0.005782258692458818
Opioid Signalling,-0.0351955623677783
DARPP-32 events,0.0019456518196704906
Nuclear Events (kinase and transcription factor activation),0.02514288986904354
Signaling by NTRK2 (TRKB),-0.04535044966245181
NGF-stimulated transcription,0.01863401380335143
Class B/2 (Secretin family receptors),0.0017395273391723235
G alpha (s) signalling events,-0.012125602184729772
RHOB GTPase cycle,0.0002743339232378102
RHOC GTPase cycle,0.005616679192899939
Vpu mediated degradation of CD4,0.001510693072255395
Vif-mediated degradation of APOBEC3G,-0.0009308109180375679
PCP/CE pathway,-0.0008034338901380089
Asymmetric localization of PCP proteins,-0.00014114549567648244
Degradation of AXIN,0.01778520672652197
Degradation of DVL,0.0015932428208944257
Hedgehog ligand biogenesis,-0.04294067870418323
Hh mutants are degraded by ERAD,0.007116743733123248
Hh mutants abrogate ligand secretion,-0.000676320779051455
Degradation of GLI1 by the proteasome,-0.03106359336534713
Degradation of GLI2 by the proteasome,-0.14994749637231397
GLI3 is processed to GLI3R by the proteasome,-0.02431414332667813
Hedgehog 'off' state,-0.020042455453252884
ABC transporter disorders,0.0017619322142729723
Disorders of transmembrane transporters,0.08959553096019512
Hedgehog 'on' state,0.04739170063984136
Defective CFTR causes cystic fibrosis,0.015597120159562224
MAPK6/MAPK4 signaling,0.004365576324240393
Regulation of PTEN stability and activity,0.0043532810023167315
Negative regulation of NOTCH4 signaling,-0.008590942038415872
Formation of HIV elongation complex in the absence of HIV Tat,0.0008823815753335832
Formation of the HIV-1 Early Elongation Complex,0.006993569821676754
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,-0.040708639445539
HIV Transcription Initiation,0.004009676805840103
RNA Polymerase II HIV Promoter Escape,-0.00010125243382014638
HIV Transcription Elongation,-3.222272178996917e-05
Transcription of the HIV genome,0.021764788409895815
Formation of HIV-1 elongation complex containing HIV-1 Tat,-0.03241027530336384
Tat-mediated elongation of the HIV-1 transcript,-0.028338794362647034
RHOBTB3 ATPase cycle,0.0006494669594555191
Signaling by TGF-beta Receptor Complex,0.011063232980837626
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,-0.009612089675694682
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,-0.016793512582615966
Pausing and recovery of Tat-mediated HIV elongation,-0.003674177156026342
Tat-mediated HIV elongation arrest and recovery,-0.10671641082548475
HIV elongation arrest and recovery,4.1664075105847715e-05
Pausing and recovery of HIV elongation,-0.001921351127878421
Estrogen-dependent gene expression,0.011066476921433789
RHOBTB2 GTPase cycle,0.004366932163978211
RHOBTB1 GTPase cycle,0.008570944481406974
RHOBTB GTPase Cycle,-0.14167128985971458
Signaling by EGFR,0.013326125002877219
EGFR downregulation,-0.002877893201083875
Signaling by FGFR,0.03197624226449816
Negative regulation of FGFR1 signaling,0.0007179916045927881
Negative regulation of FGFR2 signaling,0.000470289308771366
Negative regulation of FGFR3 signaling,0.0002549608424499682
Negative regulation of FGFR4 signaling,0.015538151263771127
Signaling by FGFR1,0.011312738768260165
Signaling by FGFR2,6.624383094390001e-05
Signaling by FGFR3,-0.0370348180530651
Signaling by FGFR4,0.0009416609023482791
Negative regulation of MET activity,-0.027879391843209176
InlB-mediated entry of Listeria monocytogenes into host cell,0.034199408907435225
Listeria monocytogenes entry into host cells,0.004813267451803597
RHOU GTPase cycle,0.003623270355058524
MAP2K and MAPK activation,0.05940327570612978
Signaling by moderate kinase activity BRAF mutants,0.0038730524532719166
Signaling by high-kinase activity BRAF mutants,0.006166864267718848
Signaling by RAS mutants,-0.034418405471159895
Signaling by BRAF and RAF1 fusions,-6.516038603490511e-05
Paradoxical activation of RAF signaling by kinase inactive BRAF,0.024397757739467573
Oncogenic MAPK signaling,0.00609684464701697
Signaling downstream of RAS mutants,0.002778965818322976
Signaling by RAF1 mutants,0.0028205534167141315
AKT phosphorylates targets in the cytosol,0.0011974482559457488
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,-0.04708274851738031
"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",0.01662811502996805
Diseases of mitotic cell cycle,0.015538419568213996
FLT3 signaling in disease,-0.015080717415819204
Aberrant regulation of mitotic cell cycle due to RB1 defects,-0.007246758735380989
Signaling by ALK in cancer,-0.11025931325606787
Signaling by FLT3 ITD and TKD mutants,-0.008360321311611676
Signaling by ALK fusions and activated point mutants,-0.00029905009102875753
RHO GTPases activate CIT,0.0006640150141525346
Extra-nuclear estrogen signaling,0.028364727592189713
Estrogen-dependent nuclear events downstream of ESR-membrane signaling,0.017065686080822737
Signaling by Activin,-0.004437117282364201
Downregulation of TGF-beta receptor signaling,-0.012399881096442607
TGF-beta receptor signaling activates SMADs,-0.0006636799973954546
G alpha (z) signalling events,-0.13800450950461865
Activation of RAC1,-0.0002779159743546221
RHOQ GTPase cycle,-0.09877368135011291
RHOH GTPase cycle,-0.02619497057311174
RHOG GTPase cycle,-0.04995977978327577
RHOJ GTPase cycle,-0.001251733497923803
RHOV GTPase cycle,0.0007681894193223616
Signaling by Insulin receptor,0.00025649577495229095
Insulin receptor recycling,-0.003545289970075124
MET activates PTK2 signaling,0.005337478031770375
MET promotes cell motility,-0.019380437610644445
MTOR signalling,-0.001474586249690259
mTORC1-mediated signalling,0.00345222158147683
Energy dependent regulation of mTOR by LKB1-AMPK,0.0039798280925706555
Diseases of Immune System,0.006153616490478264
Diseases associated with the TLR signaling cascade,-0.011167575274124953
RHO GTPases activate IQGAPs,0.0007261433502494201
RHO GTPases Activate Formins,0.028640547162581558
RHO GTPases activate PKNs,-0.0022129364079905988
RHO GTPases Activate ROCKs,-0.027510173415278245
RHO GTPases activate PAKs,-0.059991953263990865
Aberrant regulation of mitotic exit in cancer due to RB1 defects,-1.5492701354503862e-05
Pre-NOTCH Processing in Golgi,0.0018613133829886146
Signaling by ERBB4,0.0031344673164232363
Nuclear signaling by ERBB4,0.01589570416190475
Signaling by Hippo,0.03220330881400622
RHOD GTPase cycle,0.0002447014754662753
SARS-CoV-1-host interactions,-0.10891154718319636
SARS-CoV-1 activates/modulates innate immune responses,-0.029525268246333485
RND3 GTPase cycle,0.0009749043503118614
Nuclear events stimulated by ALK signaling in cancer,0.01580670159076965
HCMV Late Events,-0.03269286326727583
Formation of the beta-catenin:TCF transactivating complex,0.00992496882283648
Peptide ligand-binding receptors,-0.003742427717075029
Chemokine receptors bind chemokines,-0.002944603299777614
Translation of Structural Proteins,-0.0006540040955144665
Maturation of spike protein,0.0037848621459288514
Late SARS-CoV-2 Infection Events,-0.16958528360490305
Purinergic signaling in leishmaniasis infection,-0.00404997548660795
Cell recruitment (pro-inflammatory response),-2.3895676901778462e-05
CaMK IV-mediated phosphorylation of CREB,0.0011889756761363248
Calmodulin induced events,-0.005021494808077534
Ca-dependent events,0.019832915752783994
CaM pathway,-0.003420163767646474
G-protein mediated events,0.004532223713224094
PLC beta mediated events,-0.032340322963585626
DAG and IP3 signaling,0.0114313625083463
G-protein activation,0.006338688824201033
Ca2+ pathway,-0.002654114622875794
G beta:gamma signalling through PLC beta,0.003054670287730298
Glucagon-type ligand receptors,-0.0020215439154748615
G beta:gamma signalling through BTK,-0.0006219767186709085
G beta:gamma signalling through CDC42,0.005498077695095937
GPER1 signaling,0.0030200718158991183
ADORA2B mediated anti-inflammatory cytokines production,-5.533594643037817e-05
Anti-inflammatory response favouring Leishmania parasite infection,0.017336866817216665
Leishmania parasite growth and survival,-0.0011509702656839248
PKA-mediated phosphorylation of CREB,0.00043312016669548337
PKA activation,0.014757677022600665
Adenylate cyclase activating pathway,0.000496891322300411
Adenylate cyclase inhibitory pathway,-0.015077105947523952
FCGR3A-mediated IL10 synthesis,0.016041251773591055
Signaling by ERBB2 in Cancer,0.015982752234878984
Constitutive Signaling by Aberrant PI3K in Cancer,-0.0053342764249079385
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",-0.017311950994906455
Signaling by ERBB2 KD Mutants,-0.0005997225748785437
Signaling by ERBB2 TMD/JMD mutants,0.0025517820347957534
RND2 GTPase cycle,0.060109506744682885
Signaling by TGFBR3,0.0017822463789789478
Rev-mediated nuclear export of HIV RNA,0.002777217241194884
Transport of Ribonucleoproteins into the Host Nucleus,0.00017877197225283788
Export of Viral Ribonucleoproteins from Nucleus,-0.0006968949949769582
NS1 Mediated Effects on Host Pathways,0.004838809158260455
Viral Messenger RNA Synthesis,0.04523418293784969
NEP/NS2 Interacts with the Cellular Export Machinery,-0.0003496196862106144
Interactions of Vpr with host cellular proteins,-0.00034439740063139175
Interactions of Rev with host cellular proteins,0.002736194870966851
Nuclear import of Rev protein,-0.10033702312314853
Vpr-mediated nuclear import of PICs,0.0010330640069636061
SLC transporter disorders,-0.0004958979596897266
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),0.019646724978258576
VEGFR2 mediated cell proliferation,-0.004798307686346986
Eicosanoid ligand-binding receptors,-0.025346743795364345
RHO GTPases Activate NADPH Oxidases,0.030196809006237956
Downstream signaling of activated FGFR1,-0.0023930318862872045
FRS-mediated FGFR1 signaling,-0.0006163993831227965
Downstream signaling of activated FGFR2,0.016266168863869366
FRS-mediated FGFR2 signaling,0.0009430841784977474
FRS-mediated FGFR3 signaling,-6.28794958039105e-05
Downstream signaling of activated FGFR3,-0.09756846462085106
FRS-mediated FGFR4 signaling,-0.0004380055478660996
Downstream signaling of activated FGFR4,0.01695957589153645
RND1 GTPase cycle,-0.0732272445203536
Signaling by FGFR in disease,0.027661507602949692
Prolonged ERK activation events,0.0007071301108697942
Frs2-mediated activation,-0.0018462397916141722
Signalling to ERKs,-0.02128066764722096
Signaling by ALK,-0.003727968440400572
Signaling by FGFR2 in disease,-0.13297878211323758
Signaling by FGFR1 in disease,-0.0037596902676684985
Signaling by FGFR3 in disease,0.004539967056155814
SARS-CoV-1 targets host intracellular signalling and regulatory pathways,0.005764541390483336
Activation of SMO,-0.021958597864324227
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,0.0003875401257670948
Signaling by EGFR in Cancer,0.0008357260219697279
Constitutive Signaling by EGFRvIII,-0.008024666148195015
Signaling by EGFRvIII in Cancer,-0.00023067554111001184
Signaling by Ligand-Responsive EGFR Variants in Cancer,0.025228078198506736
Signaling by ERBB2 ECD mutants,0.022038313261134708
Infection with Mycobacterium tuberculosis,0.005646988700655587
Response of Mtb to phagocytosis,-0.00020888723773900645
Signaling by BMP,-0.004326338786829487
Early Phase of HIV Life Cycle,-0.00010864527882681736
SARS-CoV-2 modulates host translation machinery,-0.004268830089381753
RAF-independent MAPK1/3 activation,-0.004390793129615832
Negative regulation of MAPK pathway,-0.00039839878413317316
Viral mRNA Translation,0.03240346742769773
Amine ligand-binding receptors,0.0022992511357512275
Neurotoxicity of clostridium toxins,-0.00013272937856395275
SARS-CoV-2 modulates autophagy,-0.0054369712824188735
PI3K Cascade,-0.1111648695506329
IRS-mediated signalling,-0.0004858259195140717
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),0.007813666022485781
IGF1R signaling cascade,-0.014774414034203154
IRS-related events triggered by IGF1R,0.019250453641476966
Insulin receptor signalling cascade,0.0006713689810661077
WNT5A-dependent internalization of FZD4,-1.2541894784253854e-06
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",0.0002736733342980842
Induction of Cell-Cell Fusion,-0.05579962335372945
Signaling by PDGF,0.0006111824740435821
Translation of Replicase and Assembly of the Replication Transcription Complex,-0.0005224728261101146
Early SARS-CoV-2 Infection Events,0.03155957542232695
Assembly Of The HIV Virion,-0.0033894680356611677
Evasion by RSV of host interferon responses,-0.0004199303103814144
Downstream signal transduction,0.006524110446302249
p130Cas linkage to MAPK signaling for integrins,-0.005601252987579431
Signaling by Erythropoietin,0.002915606612085931
SARS-CoV-1 modulates host translation machinery,3.1535390234376804e-05
Downregulation of SMAD2/3:SMAD4 transcriptional activity,0.0022358817242606973
Maturation of nucleoprotein,0.002616917040874362
Signalling to RAS,0.003890224529385295
FGFR2 ligand binding and activation,0.0013543705066644018
Signaling by WNT in cancer,-0.005395899567045698
Signaling by AXIN mutants,-0.0001989204818905582
Signaling by CTNNB1 phospho-site mutants,0.0004390890255351265
Signaling by APC mutants,-0.015507772840518536
Signaling by AMER1 mutants,0.005929773934078789
Signaling by GSK3beta mutants,-0.0018491426609982676
CTNNB1 S33 mutants aren't phosphorylated,5.505811011672159e-05
CTNNB1 S37 mutants aren't phosphorylated,0.0012444861766876783
CTNNB1 S45 mutants aren't phosphorylated,0.008561211401424587
CTNNB1 T41 mutants aren't phosphorylated,-0.00012851050444387892
APC truncation mutants have impaired AXIN binding,-0.0701904185126493
AXIN missense mutants destabilize the destruction complex,-0.0007041498369277929
Truncations of AMER1 destabilize the destruction complex,-0.006351406509895721
"Respiratory syncytial virus (RSV) genome replication, transcription and translation",0.05870034025396494
Maturation of hRSV A proteins,-0.029544401518958912
RHO GTPases activate KTN1,-0.002745419212843557
Deactivation of the beta-catenin transactivating complex,0.01284753832596454
Repression of WNT target genes,0.003300669444879133
FGFR4 ligand binding and activation,-0.0004866332224466833
Phospholipase C-mediated cascade; FGFR4,0.007129824396490858
SHC-mediated cascade:FGFR4,0.0023073041459093584
PI-3K cascade:FGFR4,0.00868858863309359
STAT3 nuclear events downstream of ALK signaling,0.0001572012098295424
Defective pyroptosis,-0.17584846800226636
ERK/MAPK targets,-0.00013828816509828528
ERKs are inactivated,0.0011714707149761117
TGFBR3 expression,-0.015052994170308346
Erythropoietin activates Phosphoinositide-3-kinase (PI3K),0.02273646671723162
Class C/3 (Metabotropic glutamate/pheromone receptors),0.05873729710621683
FGFR1 mutant receptor activation,0.0033456002139781093
FGFR2 mutant receptor activation,0.008049405654148032
Activated point mutants of FGFR2,0.01213301704602324
Phospholipase C-mediated cascade; FGFR2,-0.0017668288126956378
PI-3K cascade:FGFR1,-0.051367173641583955
PI-3K cascade:FGFR2,-0.004692831060482872
SHC-mediated cascade:FGFR2,-0.0009036476809513928
Signaling by FGFR2 IIIa TM,-0.02238445606342945
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),-0.002042672895298134
Abortive elongation of HIV-1 transcript in the absence of Tat,0.015108359646139305
FGFR2 alternative splicing,0.02263753197255377
Regulation of PTEN mRNA translation,0.016131904006763658
Competing endogenous RNAs (ceRNAs) regulate PTEN translation,-0.0004771659679644355
NRIF signals cell death from the nucleus,5.41532223670154e-05
Signaling by KIT in disease,-0.06814577280462379
"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",-0.00011384791135017787
Loss of function of MECP2 in Rett syndrome,-0.005037163873378272
Pervasive developmental disorders,0.00012211594873515986
Disorders of Developmental Biology,-0.0007623882849254547
Disorders of Nervous System Development,0.012003382451907749
Defects in vitamin and cofactor metabolism,0.022082471627502032
Regulation of FZD by ubiquitination,0.006095841435881321
Serotonin receptors,0.004040131492657569
p75NTR signals via NF-kB,0.00908161538399647
Signaling by NTRK3 (TRKC),-0.0005281863805246022
RAF activation,-0.005030665432329225
p75NTR regulates axonogenesis,0.013248791078906374
WNT ligand biogenesis and trafficking,0.0048788870623299625
